Lowy D - Search Results

1

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, Ocampo R, Schussler J, Lowy D, Guillen D, Stoler MH, Quint W, Morales J, Avila C, Rodriguez AC, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group. Gonzalez P, et al. Among authors: lowy d. Vaccine. 2015 Apr 27;33(18):2141-51. doi: 10.1016/j.vaccine.2015.03.015. Epub 2015 Mar 18. Vaccine. 2015. PMID: 25796338 Free PMC article. Clinical Trial.

2

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles.

Chackerian B, Lenz P, Lowy DR, Schiller JT. Chackerian B, et al. J Immunol. 2002 Dec 1;169(11):6120-6. doi: 10.4049/jimmunol.169.11.6120. J Immunol. 2002. PMID: 12444114

3

Papillomaviruses infect cells via a clathrin-dependent pathway.

Day PM, Lowy DR, Schiller JT. Day PM, et al. Virology. 2003 Mar 1;307(1):1-11. doi: 10.1016/s0042-6822(02)00143-5. Virology. 2003. PMID: 12667809 Free article.

4

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells.

Lenz P, Thompson CD, Day PM, Bacot SM, Lowy DR, Schiller JT. Lenz P, et al. Among authors: lowy dr. Clin Immunol. 2003 Mar;106(3):231-7. doi: 10.1016/s1521-6616(02)00039-6. Clin Immunol. 2003. PMID: 12706410

5

Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A. Pinto LA, et al. Among authors: lowy dr. J Infect Dis. 2003 Jul 15;188(2):327-38. doi: 10.1086/376505. Epub 2003 Jul 9. J Infect Dis. 2003. PMID: 12854090 Clinical Trial.

6

Efficient intracellular assembly of papillomaviral vectors.

Buck CB, Pastrana DV, Lowy DR, Schiller JT. Buck CB, et al. J Virol. 2004 Jan;78(2):751-7. doi: 10.1128/jvi.78.2.751-757.2004. J Virol. 2004. PMID: 14694107 Free PMC article.

7

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Krüger Kjaer S, Lowy DR, Schiller JT. Pastrana DV, et al. Among authors: lowy dr. Virology. 2004 Apr 10;321(2):205-16. doi: 10.1016/j.virol.2003.12.027. Virology. 2004. PMID: 15051381 Free article.

8

Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Day PM, Baker CC, Lowy DR, Schiller JT. Day PM, et al. Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14252-7. doi: 10.1073/pnas.0404229101. Epub 2004 Sep 21. Proc Natl Acad Sci U S A. 2004. PMID: 15383670 Free PMC article.

9

Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.

Lenz P, Lowy DR, Schiller JT. Lenz P, et al. Eur J Immunol. 2005 May;35(5):1548-56. doi: 10.1002/eji.200425547. Eur J Immunol. 2005. PMID: 15832296 Free article.

10

HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.

Pinto LA, Castle PE, Roden RB, Harro CD, Lowy DR, Schiller JT, Wallace D, Williams M, Kopp W, Frazer IH, Berzofsky JA, Hildesheim A. Pinto LA, et al. Among authors: lowy dr. Vaccine. 2005 May 20;23(27):3555-64. doi: 10.1016/j.vaccine.2005.01.146. Vaccine. 2005. PMID: 15855014 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page